Inventor

WILLIS KATELYN M

US11 patents

⚠️ This page may combine multiple inventors who share the name “WILLIS KATELYN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INHIBRX INC

6 patents

US11866507B2Jan 9, 2024

Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

INHIBRX INC8 citations83

US10308720B2Jun 4, 2019

Multivalent and multispecific DR5-binding fusion proteins

INHIBRX INC3 citations71

US10093742B2Oct 9, 2018

Multispecific GITR-binding fusion proteins and methods of use thereof

INHIBRX INC4 citations71

US11976126B2May 7, 2024

Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

INHIBRX INC0 citations61

US11117973B2Sep 14, 2021

Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

INHIBRX INC0 citations61

US10844129B2Nov 24, 2020

Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

INHIBRX INC0 citations50

INHIBRX BIOSCIENCES INC

5 patents

US12590169B2Mar 31, 2026

5T4 single domain antibodies and therapeutic compositions thereof

INHIBRX BIOSCIENCES INC0 citations53

US12331132B2Jun 17, 2025

Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses

INHIBRX BIOSCIENCES INC0 citations49

US12195533B2Jan 14, 2025

Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same

INHIBRX BIOSCIENCES INC0 citations49

US12365728B2Jul 22, 2025

DLL3 single domain antibodies and therapeutic compositions thereof

INHIBRX BIOSCIENCES INC0 citations44

US12522661B2Jan 13, 2026

CD28 single domain antibodies and multivalent and multispecific constructs thereof

INHIBRX BIOSCIENCES INC0 citations43